Position in GRAL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,270,250
New position
Shares Held
33,254
first reported quarter
Ownership
0.074%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#73
of 371 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $51,871,777 across 18 Diagnostics & Research names. GRAL ranks #5 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
43,094 | $21,605,606 | |
| 2 | DHR |
Danaher Corp /De/
|
77,419 | $14,746,770 | |
| 3 | A |
Agilent Technologies, Inc.
|
22,399 | $2,975,258 | |
| 4 | RDNT |
RadNet, Inc.
|
37,274 | $2,298,687 | |
| 5 | GRAL |
GRAIL, Inc.
This page
|
33,254 | $2,270,250 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
3,884 | $2,044,692 | |
| 7 | WAT |
Waters Corp /De/
|
2,945 | $1,104,492 | |
| 8 | NTRA |
Natera, Inc.
|
3,203 | $869,453 |
All Filings in GRAL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,270,250 | 33,254 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||